A-shares closed · 港股休市 Quotes 行情 · 28 Sep 20:16 CST
28 Sep 2026 · 22:19 CST Terminal Access 终端入口 →
688505.SH上海证券交易所 · 科创板 STAR

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical 复旦张江

Chemical Pharmaceuticals 化学制药
¥8.28−¥0.08 · −0.96%Delayed 行情延迟 · 28 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥8.36
High 最高
¥8.51
Low 最低
¥8.21
Prev Close 昨收
¥8.36
Volume 成交量
844.7万股
Turnover 成交额
¥7,039.6万
Mkt Cap 总市值
¥86亿
P/E 市盈率
−68.0×
Recent Activity 近期动态All Filings 全部公告 →

One significant filing since 31 May 2026, on major holder selling (26 Aug 2026): 复旦张江关于持股5%以上股东减持股份计划公告.
自 31 May 2026 起有一份重大公告(major holder selling,26 Aug 2026):复旦张江关于持股5%以上股东减持股份计划公告。

Price History 价格走势

125 trading days 个交易日 · High 最高 ¥8.95 · Low 最低 ¥6.68
7.007.508.008.50
Volume 成交量
3,728.7万
Mar 26May 26Jul 26Aug 26Sep 26

Against Its Own History 与自身历史比较

−68.0×
Median 中值 65.7× · Range 区间 37.5× to 191.8× · 10 periods 期
3.99×
Median 中值 3.91× · Range 区间 2.82× to 7.35× · 20 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥7.38−¥0.12—¥2.083.55×
31 Mar 2026 一季报¥7.97——¥2.053.89×
31 Dec 2025 年报¥8.30−¥0.15—¥2.044.07×
30 Sep 2025 三季报¥9.12−¥0.06—¥2.184.19×
30 Jun 2025 中报¥8.66−¥0.02—¥2.203.94×
31 Mar 2025 一季报¥8.01——¥2.233.60×
31 Dec 2024 年报¥7.67¥0.04191.8×¥2.223.45×
30 Sep 2024 三季报¥8.25¥0.1082.5×¥2.273.64×
30 Jun 2024 中报¥6.40¥0.1158.2×¥2.272.82×
31 Mar 2024 一季报¥7.40——¥2.283.25×
31 Dec 2023 年报¥9.23¥0.1183.9×¥2.274.06×
30 Sep 2023 三季报¥10.36¥0.1857.6×¥2.254.60×
30 Jun 2023 中报¥8.63¥0.2337.5×¥2.243.86×
31 Mar 2023 一季报¥9.77——¥2.204.44×
31 Dec 2022 年报¥8.35¥0.1364.2×¥2.193.81×
30 Sep 2022 三季报¥8.29¥0.1459.2×¥2.153.85×
30 Jun 2022 中报¥10.15——¥2.074.91×
31 Mar 2022 一季报¥12.23——¥2.105.81×
31 Dec 2021 年报¥14.10¥0.2167.1×¥2.106.71×
30 Sep 2021 三季报¥14.58¥0.1976.7×¥1.987.35×

Consensus Forward EPS 机构预测每股收益

No broker forecasts for this company yet 暂无机构预测

Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA